Reading Time: 7 minutes This blog is part of our Symposium Blogathon series – where we are counting down to the 33rd International Symposium. Numbers in bold blue type
Reading Time: 2 minutes This blog is part of our Symposium Blogathon series – where we are counting down to the 33rd International Symposium. Numbers in bold blue type correspond
Reading Time: 2 minutes This blog is part of our Symposium Blogathon series – where we are counting down to the 33rd International Symposium. Numbers in bold blue type correspond
Reading Time: 6 minutes This blog is part of our Symposium Blogathon series – where we are counting down to the 33rd International Symposium. Numbers in bold blue type
Reading Time: 2 minutes It’s that time of year again where the research team at the Association are counting down to the start of the largest scientific and medical
Reading Time: 6 minutes A recent paper (October 2022), published in the journal Journal of Pathology: Clinical Research suggests that evidence of MND can be seen inside people years before
Reading Time: 4 minutes Receiving a diagnosis of Motor Neurone Disease (MND) can often lead to people feeling that they are losing control within their lives. Researchers at the
Reading Time: 6 minutes On Tuesday 4 October 2022, a new paper was published which investigated the risk of developing a neurodegenerative disease, such as MND, among former Scottish
Reading Time: 6 minutes On 29th September 2022 AMX0035, a treatment for Motor Neurone Disease (MND) was approved by the Food and Drug Administration (FDA) in the United States.
